Patent application number | Description | Published |
20100048418 | ANTIGEN SCREENING SYSTEM - Methods and compositions for identifying antigens of human lymphocytes are provided herein. | 02-25-2010 |
20100260791 | CHLAMYDIA ANTIGENS - antigens (e.g., polypeptides, polypeptide fragments, and fusion proteins) are provided. Also provided are vaccines and pharmaceutical compositions for treating or preventing a bacterial infection, such as | 10-14-2010 |
20110020386 | VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE - is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in | 01-27-2011 |
20110076288 | Compositions for and Methods of Identifying Antigens - Replicable libraries having discrete members in defined locations for screening for antigens to a pathogenic organism are provided. Also provided are methods for using such libraries as well as a specific antigen, CT788, which induces T-cell activation during a | 03-31-2011 |
20110293664 | CHLAMYDIA ANTIGENS AND USES THEREOF - Disclosed are novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. Methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses) comprising administering an immunogenic composition including one or more of the novel antigens may be used for prophylaxis and/or treatment of chlamydia-mediated diseases. | 12-01-2011 |
20120135025 | CHLAMYDIA ANTIGENS AND USES THEREOF - The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein. | 05-31-2012 |
20120189649 | Vaccines and Compositions Against Streptococcus Pneumoniae - is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in | 07-26-2012 |
20130102496 | ANTIGEN SCREENING SYSTEM - Methods and compositions for identifying antigens of human lymphocytes are provided herein. | 04-25-2013 |
20140120129 | CHLAMYDIA ANTIGENS - antigens (e.g., polypeptides, polypeptide fragments, and fusion proteins) are provided. Also provided are vaccines and pharmaceutical compositions for treating or preventing a bacterial infection, such as | 05-01-2014 |